May 18th, 2018
In 2007, the Legatum Foundation, one of the founding investors in the END Fund, first invested in a pilot program for NTDs in Rwanda. Between 2008-2017, almost 52 million generously donated treatments were delivered valued at over $2.7 million. This treatment led to a 30% decrease in the prevalence of intestinal worms between 2008 to 2014.
Read more in our report on the tremendous progress made in Rwanda and what it will take to have an NTDs-free country.
For more information see our Rwanda Report Release and Closing Release.